Aptahem enters collaboration agreement with Granzer Regulatory Consulting and Services to prepare for clinical stage
Aptahem AB (publ), announce today that the company enters a collaboration agreement with the German company Granzer Regulatory Consulting and Services to prepare for applications to the European Medicines Agency (EMA) and the Food and Drug Administration (FDA). Granzer is a well established consultant company within regulatory support and has expertise in oligionucletides and aptamers for pharmaceutical projects.By entering this agreement, Aptahem takes the next step to prepare for regulatory documentation leading to clinical trials regarding their lead candidate Apta-1 for the treatment of